Overview
The goal of this clinical trial is to improve health outcomes for incarcerated individuals by increasing medications for opioid use disorder (MOUD) use, using scalable and cost-effective methods that could be applied more broadly in the criminal justice system.
Description
This trial will evaluate a systems-change approach to scaling medications for opioid use disorder (MOUD) across 120 prisons in 12 U.S. states. Researchers will test two promising, implementation strategies-policy academy and multisite learning collaborative-commonly used in healthcare, education, and community development. The focus on MOUD is driven by strong evidence of its efficacy, low penetration in prisons, significant health inequities among incarcerated populations, and the high risk of overdose deaths during reentry into the community.
Eligibility
Inclusion Criteria - Sites:
- Have an interest in embedding or increasing the use of MOUD within their site
- Have the funds to pay for medication for the duration of the study (24 months)
- Agree to implement or continue the use of at least one medication for opioid use disorder
- Have leadership support at all levels including from Secretary of DOC, medical director, wardens, etc.
- Sign a memorandum of Understanding (MOU) or Information Sheet
- Agree to provide data described in the Information Sheet
Exclusion Criteria:
- Failure to meet eligibility criteria
